Exclusive

Emma Marcegaglia

The quiet influence over European business

From the factory floor of her father’s steel business, to some of the biggest boardrooms in Europe, the rise and rise of Emma Marcegaglia...
Ethereum

The crypto balloon is rising again, with new player Ethereum hanging...

By HAL WILLIAMS BITCOIN’S value will more than double by the end of 2018. Buy, buy, buy! But, um, not Bitcoin. And hey, relax your shoulders:...
South Sudan Flag

The Big Fail: South Sudan

Where did it all go wrong? Designed as place where new business could survive and prosper, South Sudan’s devastating collapse into corruption has driven away...

Robert J Schiller: Fighting the Next Global Financial Crisis

What do people mean when they criticise generals for fighting the last war? It’s not that generals ever think they will face the same...
TV remote channels

Reports of Viacom’s Death Are Greatly Exaggerated

Time was when Viacom’s infamous booming audio logo trumpeted the sound of success. And in the risk-ridden world of TV entertainment shows it held...
Purple Grapes - wine investment illustration

Balkan Trade War Heating Up

Fruit and vegetables have become the unlikely weapons as bad neighbours sharing borders feel the discord of strained relations… By Darren Parkin SINCE a fragile peace...
Brandenburg Gate

The fail of Berlin?

After months of quiet anxiety about trade conditions for the country, the voices of Germany’s business leaders are becoming louder as they believe they...
Banxe unites crypto and cash

Good reasons cryptocurrency is likely to become ‘the future of commerce’

Analyst BRIAN G. SEWELL speculates that Bitcoin et al, although flawed, will change the way the world does business I WOULD rather see the SEC...
Cost of going green

Eco-frenzy or eco-friendly – the real cost of going green

Market expectations and tangible cost benefits are the new cornerstones of corporate sustainability goals. NAOMI SNELLING reports Financial experts point out that as the global...
Gene therapy

Merger brings gene therapy aid for infants closer to production

FDA approves ‘breakthrough therapy’ designation for novel treatment NOVARTIS has announced a multi-billion dollar agreement and plan of merger with AveXis to acquire the US-based...